Literature DB >> 16158939

Targeting of focal adhesion kinase by flavonoids and small-interfering RNAs reduces tumor cell migration ability.

Ying-Tang Huang1, Lung-Ta Lee, Ping-Ping H Lee, Yung-Sheng Lin, Ming-Ting Lee.   

Abstract

Focal adhesion kinase (FAK), a member of a growing family of structurally distinct protein tyrosine kinases (PTK), has been linked to specific phosphorylation events, and the elevation of FAK activity in human carcinoma cells is associated with increased invasive potential. In the present study, therefore, we developed two experiments to test the hypothesis that FAK is a determinant of, and plays an important role in, regulating tumor cell migration. In the first, the biological functions of FAK were examined using flavonoid inhibition. MiaPaCa-2 cells, treated with luteolin (Lu) and quercetin (Qu), were used to dampen FAK phosphorylation and protein expression by parallel suppression of cell migration ability. The second experiment involved suppression of FAK expression using small-interfering RNAs (siRNA) specific to FAK. While not affecting cellular proliferation or apoptosis, the siRNA targeting FAK almost completely inhibited FAK protein expression in MiaPaCa-2 cells and potently blocked the cell migration mediated by FAK. Our results show that FAK functions as a key regulator of cell migration, and that FAK activity can be suppressed by specific FAK siRNA, and by luteolin and quercetin. It appears reasonable to conclude, therefore, that suppression of FAK protein has a significant impact on tumor cell invasiveness.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16158939

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  13 in total

Review 1.  Mechanisms of combined action of different chemopreventive dietary compounds: a review.

Authors:  Theo M de Kok; Simone G van Breda; Margaret M Manson
Journal:  Eur J Nutr       Date:  2008-05       Impact factor: 5.614

2.  Expression and clinical significance of focal adhesion kinase and adrenomedullin in epithelial ovarian cancer.

Authors:  Mingqun Li; L I Hong; Meimei Liao; Guanglin Guo
Journal:  Oncol Lett       Date:  2015-05-27       Impact factor: 2.967

Review 3.  Focal adhesion kinase as a cancer therapy target.

Authors:  Vita M Golubovskaya
Journal:  Anticancer Agents Med Chem       Date:  2010-12       Impact factor: 2.505

Review 4.  Luteolin, a flavonoid with potential for cancer prevention and therapy.

Authors:  Yong Lin; Ranxin Shi; Xia Wang; Han-Ming Shen
Journal:  Curr Cancer Drug Targets       Date:  2008-11       Impact factor: 3.428

5.  Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion.

Authors:  X N Meng; Y Jin; Y Yu; J Bai; G Y Liu; J Zhu; Y Z Zhao; Z Wang; F Chen; K-Y Lee; S B Fu
Journal:  Br J Cancer       Date:  2009-06-30       Impact factor: 7.640

6.  Apigenin inhibits NNK-induced focal adhesion kinase activation in pancreatic cancer cells.

Authors:  Hung Pham; Monica Chen; Hiroki Takahashi; Jonathan King; Howard A Reber; Oscar Joe Hines; Stephen Pandol; Guido Eibl
Journal:  Pancreas       Date:  2012-11       Impact factor: 3.327

7.  Small molecule chloropyramine hydrochloride (C4) targets the binding site of focal adhesion kinase and vascular endothelial growth factor receptor 3 and suppresses breast cancer growth in vivo.

Authors:  Elena V Kurenova; Darell L Hunt; Dihua He; Andrew T Magis; David A Ostrov; William G Cance
Journal:  J Med Chem       Date:  2009-08-13       Impact factor: 7.446

8.  The expression of integrinbeta1 and FAK in pituitary adenomas and their correlation with invasiveness.

Authors:  Feng Wang; Kai Shu; Ting Lei; Delin Xue
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-10-10

9.  The flavonoid quercetin induces apoptosis and inhibits migration through a MAPK-dependent mechanism in osteoblasts.

Authors:  Tae Wook Nam; Chong Il Yoo; Hui Taek Kim; Chae Hwa Kwon; Ji Yeon Park; Yong Keun Kim
Journal:  J Bone Miner Metab       Date:  2008-11-01       Impact factor: 2.626

10.  CK2 inhibitor CX-4945 blocks TGF-β1-induced epithelial-to-mesenchymal transition in A549 human lung adenocarcinoma cells.

Authors:  Jiyeon Kim; Seong Hwan Kim
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.